Yes useful information, but still a bit confusing.
There are 7 trials listed, yet when IMU provided its "Outlook for 2024" they said there were 5 clinical trials ongoing. I don't believe we have had 2 new trials start this year.
Also re Checkvacc TNBC trial, as reported on 31/10/23:
After completion of the current cohort 4, the data derived from this trial will be used to inform our other CF33 clinical developments, and resources and finances from this study
will be re directed to our priority programs.
Perhaps one of our more knowledgeable posters can clarify these apparent anomalies.
Yes useful information, but still a bit confusing. There are 7...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $420.8M | |||
| Open | High | Low | Value | Volume |
| 5.7¢ | 5.8¢ | 5.6¢ | $78.50K | 1.381M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 314029 | 5.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.8¢ | 852520 | 9 |
View Market Depth
| Last trade - 10.47am 26/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |